References
Bianchetti MG, Simonetti GD, Ferrari P (2003) The distinction between Liddle syndrome and apparent mineralocorticoid excess. Pediatr Nephrol 18:607–608
Liddle GW, Bledsoe T, Coppage WS (1963) A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 76:199–211
New MI, Levine LS, Bigliori EG, Pareira J, Ulick S (1977) Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 44:924–933
Oberfield SE, Levine LS, Carey RM, Greig G, Ulick S, New MI (1983) Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 56:332–339
Shackleton CHL, Honour JW, Dillon MJ, Chantler C, Jones WA (1980) Hypertension in a four-year-old girl: gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids. J Clin Endocrinol Metab 50:786–792
Fiselier TJW, Otten BJ, Monnens L, Honour JW, Munster PJJ van (1982) Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month old child. Horm Res 16:107–114
Assadi FK, Kimura RE, Subramanian U, Patel S (2002) Liddle syndrome in a newborn infant. Pediatr Nephrol 17:609–611
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–716
Brown NJ (2003) Eplerenone. Cardiovascular protection. Circulation 107:2512–2518
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Monnens, L., Levtchenko, E. Distinction between Liddle syndrome and apparent mineralocorticoid excess. Pediatr Nephrol 19, 118–119 (2004). https://doi.org/10.1007/s00467-003-1311-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-003-1311-1